藥理學(xué)教學(xué)課件:Chapter 19 Analgesics_第1頁(yè)
藥理學(xué)教學(xué)課件:Chapter 19 Analgesics_第2頁(yè)
藥理學(xué)教學(xué)課件:Chapter 19 Analgesics_第3頁(yè)
藥理學(xué)教學(xué)課件:Chapter 19 Analgesics_第4頁(yè)
藥理學(xué)教學(xué)課件:Chapter 19 Analgesics_第5頁(yè)
已閱讀5頁(yè),還剩86頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1Chapter19Analgesics2paintwocomponentssomaticsensationaffective(emotion)1.ConceptSection132.PaintransmissionpathwayNoxiousstimuliPGsK+、H+BK5-HTPrimaryafferentfibres(C/Aδ)nociceptorSpinalcordLimbicsystemSomato-sensorycortexmoodeffect,theaffectiveaspectofpainthesensoryaspectofpainMedullaMidbrainDorsalhorn4DescendingpaininhibitorypathwaysLocalinhibitoryinterneuroninspinalcordPainAscendingpaintransmissionpathwaysEndogenousopioidpeptides5

MedullaMidbrainCortex

Spinal

cordDorsalhornVentralcaudalthalamusPGsK+、H+BK5-HTNSAIDsLocalanestheticsOpioidanalgesics,AntidepressantsandGeneralanaestheticsSitesofactionofdifferentdrugs62.Paina.Acutepain(sharppain):superficialpain,quickresponseofsuddenonset,conductedbyAnervefibersb.Chronicpain(dullpain):morelingeringandaching,conductedbyCnervefibers7severe,sharppainopioidanalgesics(eg.Morphine)inflammation,elevatedtemperature,chronic-dullpainNSAIDs(eg.Aspirin)smoothmusclecolic(eg.biliaryorrenalcolic)

anginapectorisinducedbycoronaryarteryspasm

trigeminalpain3.Durgtreatmentofpaincholinoceptor-blockingdrugs(eg.Atropine)vasodilatordrugs(eg.Nitroglycerin)

Carbamazepine8AnalgesicsDrugswhichactonCNS,couldrelieveoralleviateseverepainandunhappymoodwithoutaffectingothersenseperception,andconsciousness.1.Concept9FullagonistofopioidreceptorsPartialagonistofopioidreceptorsOtheranalgesics2.Classification10Section2FullagonistofopioidreceptorsHistoryofAnalgesicsIn1803,Serturnerisolatedapureactivealkaline---Morphine.In1962,ChinesepharmacologistsproposedtheanalgesicsiteofopioidsislaminaeIIIofperiventricularandperiaqueductalgraymater.Inearly70’,Opioidreceptorsfoundandsuccessfulclonedin1993In1975,firstendogenousOpioidpeptide(endorphin,內(nèi)啡肽)wasfound.1992~1993197319621975

analgesicsiteislaminaeIIIofperiventricularandperiaqueductalgrayareaputforward“receptors”foropiateanalgesicsinbrainisolatedthefirst“endogenousopioidpeptide”andnamedenkephalin腦啡肽clonedthreeopioidreceptors:μ

κ

δResearchonanalgesicmechanismsSubstancePandendogenous

analgesicsystemSubstancePisaneuropeptide:ashort-chainpolypeptidethatfunctionsasaneurotransmitterandasaneuromodulator.

SubstancePisinvolvedinthetransmissionofpainimpulsesfromperipheralreceptorstothecentralnervoussystem.17enkephalinsPresynapticterminalPostsynapticneuronThecellularmechanismsofanalgesiamorphine18

Presynapticinhibition:activationofopioidreceptorsonpresynapticnerveterminals.Closeavoltage-gatedCa2+channel,decreaseCa2+input,andtherebyreducetransmitterrelease.ThecellularmechanismsofanalgesiaPostsynapticinhibition:activationofpostsynapticopioidreceptors.OpenK+channelsonpostsynapticneurons,increaseK+output,andtherebycausehyperpolarizationandthusinhibitpostsynapticneurons.19SpinalcordDorsalhornenkephalinsCa2+Ca2+谷氨酸神經(jīng)肽PresynapticterminalPostsynapticneuronenkephalins

AMPA受體:α-氨基-3-羥基-5-甲基-4-異惡唑丙酸受體NK1:P物質(zhì)神經(jīng)激肽121SitesofanalgesiaSupraspinal脊椎areas:thalamus丘腦,periventricular,

periaqueductalgrayareaSpinalcord:substantiagelatinosa脊髓膠狀質(zhì)22EndogenousopioidpeptidesThreemainfamilies:

Enkephalinsmet-enkephalinleu-enkephalin

Endorphins:β-endorphine

Dynorphins強(qiáng)啡肽:

dynorphineA,BEndogenousOpioidPeptidesOpiodsproduceeffectsthatmimictheactionofendogenouspeptideneurotransmitters(1)Endorphins(內(nèi)啡肽類(lèi)):M-enkephalin(甲硫氨酸腦啡肽),L-enkephalin(亮氨酸腦啡肽),β-endorphin(β-內(nèi)啡肽)(2)Enkephalins(強(qiáng)啡肽類(lèi)):dynorphineADistributionandfunction

ofopioidreceptors(1)Opioidreceptorsatthalamic,laminaeI,II,III(substantiagalatinosa脊髓膠質(zhì)區(qū))ofspinalcordandperiventricularandperiaqueductalgraymatter.relatedtotheintergretion,perception,reactionandsensationofpain.(2)Opioidreceptorsatlimbicsystemincludinglocusceruleus(藍(lán)斑),anteriortemporalandorbital(前顳與眶)frontalcortexpartsofhypothalamusandamydala(杏仁).involvedinemotion,psychitricactivity,mayberelatedtoeuphoria,toleranceanddependence.(3)Opioidreceptoratnucleussolitarius(孤束核)isthelocationofcoughcenter.(4)Opioidreceptoratareapostremaofmedulla

isthechemoceptortriggerzonegoverningnauseaandemesis.TypesofopioidreceptorsThemajoreffectsoftheopioidsaremediatedby4familiesofreceptors,designatedbyμ、κ、σandδ,eachofwhichexhibitsadifferentspecificityforthedrugsitbinds.Fourmajoropioidreceptors:(1)μ(mu)-receptorsTheanalgesicpropertiesoftheopioidsareprimarilymediatedbytheμ-receptor,andforsomemajorunwantedeffects(e.g.respiratorydepression,euphoria,sedationanddependence).Mostoftheanalgesicopioidsareμ-receptoragonist.μ-receptorisdividedinto1and2subtypes,involvinginsupraspinalanalgesia,respiratoryinhibition,euphoria,physicaldependenceandmiosis.(2)δ(delta)-receptorsareprobablymoreimportantintheperipherybutmayalsocontributetoanalgesia.

-receptorisdividedinto1and2subtypes,involvedinspinalanalgesia,respiratorydepression,euphoria,physicaldependence.(3)κ(kappa)-receptorscontributetoanalgesiaatthespinallevelandmayelicitsedation,dysphoria(焦慮)andmiosis.producerelativelyfewunwantedeffectsanddonotcontributetodependence.Someanalgesicsarerelativelyκselectively.(4)σ(sigma)-receptors

arenottrueopioidreceptorsbutarethesiteofactionofcertainpsychotomimeticdrugs,towhichsomeopioidsalsobind.involvinginanalgesia,dysphoria(焦慮),hallucination,cardiacinhibition,miosis.33Opioidreceptorssupraspinalanalgesia,

sedation,euphoria,respiratorydepression,miosis,

dependencespinalanalgesia,sedationdysphoria,hallucinationspinalanalgesia,

respiratorydepression,sedation,euphoria,dependence

*

:

:

::Subtypesandeffectsofopioidreceptors

:excitation

:inhibitionST

effects

pain

resp

HR-

BP-

pupil

Table.functionaleffectsassociatedwiththemaintypesofopioidreceptor

μδκanalgesia

Supraspinal+++--Spinal+++++Peripheral

++-++Respiratorydepression+++++-Pupilconstriction++-+ReducedGImotility+++++euphoria+++--dysphoria--+++sedation++-++Physicaldependence+++-+SignalTransduction

AllopioidreceptorsarecoupledtoinhibitoryG(Gi)proteinsandinhibitadenylylcyclase(AC).TheymayalsobeassociatedwithionchannelstoincreaseK+efflux(hyperpolarization)orreduceCa2+influx,thusimpedingneuronalfiringandtransmitterrelease.37ExtracellularCytoplasmicNH2HOOCOpioid

receptorsGprotein-coupledreceptorsClassifications:

--Opiates:

papaverine罌粟堿,morphine,codeine--Syntheticcompounds--AdditionalanalgesicsAnalgesicsCharacteristics①Potencyanalgesia②Dependence--narcotic(麻醉)analgesics--addictionanalgesics--opioidanalgesics40

Theflowerofpapaversomniferum41Opium421803Serturnerisolatedapureactivealkalinesubstancefromopium.Heproposedthename“morphine”foritafterMorpheus.Morphine43Structure-activityrelationship海洛因嗎啡納洛酮OH44Pharmacokineticsabsorptionexcretiondistribution

freedrugoralFirstpasseliminationsc.im.bloodliverplacental

fetuslittlecrosstheBBB,butenoughforitsfunctionmetabolismmorphine-6-glucuronidekidney,

breast45PharmacologicalactionsCNSSmoothmuscles3.Cardiovascularsystem4.Others46Pharmacologicalactions1.CNSeffects:principaleffectsanalgesiaeuphoriasedationrespiratorydepression

tolerance47(1)Analgesiapowerfulpain-relievingeffectalltypesofpains:*constant,dull﹥intermittent,sharp(easyaddiction)poorefficiencyonneuropathicpain

withoutaffectingconsciousnessandothersenseperception

duration:4-5h

1.CNS48

(2)Sedationandeuphoria

toleranceofpaindrowsinessandcloudingofmentation

sleepinducedandarousedeasily

*Euphoria

asenseofcontentmentandwell-being

relieveanxietyanddistress

Sedationthemainreasonfordrugabuse49Activatetheopioidreceptoratlimbicsystemandlocusceruleus(藍(lán)斑)Mechanisms:50

respiratoryrate,tidalvolume

occursatordinarydoses,

dose-related

themostcommoncauseofdeathfromacutepoisoningMechanisms:thesensitivityofrespiratorycentertoincreasedCO2tensionrespiratorymodulatorycenter(3)Respiratorydepression51PulmonaryedemadyspneaAcuteleftventriculardysfunctionshortofbreath(respiratorycenter)

CO2retentionanxietyanddistressAlveolarhypoventilation

morphineReducecardiacpreloadandafterloadReducethesensitivityoftherespiratorycentertoincreasedCO2SedationCardiacasthma

andmorphinetherapy

53

(4)Coughsuppressionbyinhibitingcoughcenterdirectly

Hasantitussiveeffect54

(5)Miosis:

pinpointpupils

ischaracteristicofacutepoisoningblockedbynaloxoneandatropineNauseaandvomiting:

activatethebrainstemCTZ

55(6)Others

↓releaseofgonadotropin-releasinghormone(GnRH)↓releaseofcorticotropin-releasinghormone(CRF)↓concentrationofluteinizinghormone(LH),folliclestimulatinghormone(FSH)↓adrenocorticotropichormone(ACTH)↑prolactinrelease56Pharmacologicalactions2.SmoothMuscleStimulating

GastrointestinalsystemBiliarytractUrinaryBronchia57(1)Gastrointestinaltract

delayspassage2.Smoothmusclesystem

secretionofdigestiveglandindigestioncentralinhibition

acallofnaturedefecationreflexsphinctertoneGITtone

GITmotilityabsorptionofwaterconstipationClinicaluses?58

biliarycolic

constrictbiliarysmoothmuscleconstrictOddi'ssphincterpressureinthebiliarytract(2)BiliarytractMedicine?59(3)Othersmoothmuscle

①constrict

ureteralsmoothmuscleconstrictbladdersphincterurinaryretention

③antagonize

oxytocin(縮宮素)

uterinetone

prolonglabor

②constrictbronchialsmoothmusclebronchial

asthma

60

orthostatichypotensionMechanisms:

releaseofhistaminevasomotorcenter3.Cardiovascularsystem(1)peripheralarterialandvenousdilatation(2)intracranialpressuresecondarytorespiratorydepression614.Otheractionsinhibitimmunesystem

histaminerelease

bronchospasmflushingarteriolardilatation62ClinicalusesAnalgesia

acute,severepain,particularlyin

terminalcancermyocardialinfarctionrenalandbiliarycolic(atropine)short-termuseonlywhenothersfailed2.*Cardiacasthma

3.Antidiarrhea63PulmonaryedemadyspneaAcuteleftventriculardysfunctionshortofbreath(respiratorycenter)

CO2retentionanxietyanddistressAlveolarhypoventilationmorphineReducecardiacpreloadandafterloadReducethesensitivityoftherespiratorycentertoincreasedCO2SedationCardiacasthma

andmorphinetherapy

64(1)Mechanisms:①

peripheralarterialandvenousdilationpreloadandafterloadpulmonaryedema②

sedation

anxietyanddistress

oxygenconsumption

thesensitivityofrespiratorycenterto

CO2

shortnessofbreathCardiacasthma651.Generaladverseeffects1dysphoria5Biliarycolic2Respiratorydepression6Urinaryretention3Nauseaandvomiting7Posturalhypotensionaccentuatedbyhypovolemia4Constipation8IncreasedintracranialpressureAdverseeffects662.AcuteMorphinePoisoning673.Toleranceanddependence(1)Tolerance

agraduallossineffectivenessinCNSwithfrequentlyrepeatedadministration,needlargerdosestoachievethesameclinicaleffect.

Characteristic:

ordinarytherapeuticdoses2-3wlargedosesatshortintervalsreadily

developnottomiosis,constipation68

physicaldependence:

withdrawalsyndromepsychologicaldenpendence:euphoriapromotecompulsiveuseandcraving(2)Dependence69戒斷綜合癥狀

SYMPTOMSOFWITHDRAWAL腹瀉出汗抑郁震顫衰弱肌痙攣寒戰(zhàn)渴求藥物頭痛、嗎啡與藍(lán)斑核μ受體結(jié)合后,NA能神經(jīng)元受抑制71

rhinorrhealacrimation

chills

gooseflesh(piloerection)yawningsweatingmuscularachesvomitingdiarrhea

anxiety

hostilityhyperventilation

Withdrawal

syndromeofOpioid72Contraindications

reasonsthatresultinpainarenotclear

obstetriclabor,breastingperiod

corpulmonale,bronchialasthma

headinjuries

seriouslyimpairedhepaticorrenalfunction

newborninfant,infant

biliaryandrenalcolic73Codeine(methyl-morphine)Characteristics:1.hasahigher

oralefficacy

2.weakeranalgesia,about1/10-1/12,antitussive:1/43.usedinmoderatepain4.mailyuseasantitussive,severe

drycough.

74Pethidine(dolantin,meperidin)

analgesia:weaker(1/7-1/10)andshorter(2-4h)sedation,euphoria,respiratorydepression:equal

noantitussiveactionMetabolismsnormeperidine

muscle

tremors,witches,convulsion2.Pharmacologicalproperties(1)CNS75(3)Cardiovascularsystem

similartomorphine(2)Smoothmuscle

lessconstipationandurinaryretention

donotprolonglabor

mayinducebiliarycolic

largedosesthecontractionofbronchialsmoothmuscle763.Clinicaluses(1)Analgesiaobstetriclabor

but

shouldnotbeusedin2-4hbeforelabor

donotlongtimeuseinchronicpain.

(2)Cardiacasthma(3)Premedicationinanesthesia

sedative,anxiolytic,andanalgesia77

(4)Artificialhibernation

pethidinechlorpromazinepromethazinelyticcocktailⅠ4.AdverseeffectsCNSexcitatorysymptoms

muscletremors,twitches,convulsion

shouldbecombinedwithanticonvulsive

drugswhentreatoverdosepoisoning(2)somesymptomslikeatropine78IncreasedCNSdepression,particularlyrespiratorydepressionOpioidanalgesics

MAOIsTricyclicantidepressantschlorpromazinepromethazineSedative-hypnoticsAbsolutecontraindicationtopethidine,relativecontraindicationtootheropioidanalgesics,becauseofhighincidenceofhyperpyreticcomaDrug–Druginteractions79Methadone美沙酮Characteristics:

1.analgesia:equaltomorphine2.givereliableeffectsorally,longerdurationofaction3.toleranceandphysicaldependencemoreslowly4.withdrawalsignsattenuatedbutprotracted5.detoxificationofthemorphineandheroindependentaddict80Fentanyl

Characteristics:

1.moreanalgesicpotentcythanmorphine:100times2.hasarapidonsetandshortdurationofaction

3.highlipid-soluble,transdermaladministration4.+droperidol(氟哌利多)

neuroleptanalgesia(神經(jīng)阻滯鎮(zhèn)痛術(shù))

orusuallycombinedwithanaesthetics5.highdosecausetruncalrigidity81ShortactingfentanylsufentanilalfentanilAgonistsmixedAgonists/AntagonistsAntagonists

WEAK:codeinepentazocineSTRONG:methadonemorphine

pethidine

buprenorphinenalbuphinelongactingnaltrexonenaloxoneClassificationofopioidanalgesics82

Section3Partialagonistsofopioidreceptor

83Pentazocine噴他佐辛Characteristic:

κ,σagonist,μweakantagonist

1.CNSanalgesia:1/3respiratorydepression:1/2*psychomimeticaction(60-90mg)

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論